Centers for Disease Control and Prevention

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Centers for Disease Control and Prevention sits in the top decile of US sponsors by registered trial count (#202 of 15,742 sponsors by registered trial count).

139 total trials 3 currently recruiting 131 completed early-phase tilt top decile by trial count

Centers for Disease Control and Prevention: 139 sponsored US clinical trials, 3 recruiting.

Centers for Disease Control and Prevention sponsors 139 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 131 completed. 18 of these trials are in Phase 3-4 (later-stage) and 62 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 12 trials.

Top-decile sponsor footprint

Centers for Disease Control and Prevention ranks in the top decile of sponsors by registered trial count (#202 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 84/100

131 of 134 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

139 total, page 2 of 3

COMPLETED NA

Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women

NCT00136227

COMPLETED Phase 1

Evaluating Tools for Health Promotion and Disease Prevention

NCT00164658

COMPLETED NA

TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection

NCT00164450

TERMINATED Phase 2

Botswana Tenofovir Oral HIV Prophylaxis Trial

NCT00111150

COMPLETED Phase 2

Competency Training, Staff Performance, & Family Outcomes

NCT00336193

COMPLETED Phase 1

Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM

NCT00137631

COMPLETED Phase 4

VaxTeen Hepatitis B Vaccine Booster Study

NCT00144313

COMPLETED NA

Research to Improve Smoke Alarm Functioning and Maintenance

NCT00139126

COMPLETED NA

Computerized Risk Assessment in an Employee Population

NCT00153335

COMPLETED Phase 4

CHOICE: Communicating Health Options Through Information and Cancer Education

NCT00134589

COMPLETED Phase 1

Youth Empowerment Solutions for Peaceful Communities

NCT00164593

COMPLETED Phase 1

Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents

NCT00137644

COMPLETED Phase 3

Adherence With Iron Sprinkles Among High-Risk Infants

NCT00136266

COMPLETED Phase 2

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

NCT00131677

TERMINATED NA

Multi-level Interventions for STD Prevention Among Adolescents

NCT00146406

COMPLETED NA

Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening

NCT00207636

COMPLETED

Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners

NCT00153452

COMPLETED NA

Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women

NCT00207480

COMPLETED Phase 1

Lay Health Advisors for Sexually Transmitted Disease Prevention

NCT00207506

COMPLETED Phase 2

Increasing Physical Activity Among Overweight Women With Mobility Disabilities.

NCT00164515

COMPLETED Phase 2

The Treatment Advocacy Program

NCT00164333

COMPLETED Phase 1

An Arts-Based Initiative for the Prevention of Violence Against Women and Girls

NCT00164541

COMPLETED

ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader

NCT00252109

COMPLETED Phase 2

TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment

NCT00164463

COMPLETED NA

ADAPT-POL: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques

NCT00252083

COMPLETED Phase 2

HIP: HIV Intervention for Providers

NCT00164398

COMPLETED Phase 2

Project TEAM: Teaching HIV Prevention in the HIV Clinic

NCT00164320

COMPLETED

Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)

NCT00146419

COMPLETED NA

Racial Disparities in Pneumococcal Vaccination in Managed Care

NCT00229762

COMPLETED Phase 1

University of Oklahoma Parenting Program Attrition

NCT00153465

COMPLETED Phase 1

Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

NCT00164411

COMPLETED NA

Linking Lives: Building Quality Parent Components for School-Based Health Programs in Middle Schools

NCT00136279

COMPLETED Phase 2

Health Promotion of People With Disabilities

NCT00164489

COMPLETED Phase 2

Limb Loss Self-Management Program

NCT00164502

COMPLETED NA

Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection

NCT00132457

COMPLETED Phase 1

Promoting Clinical Preventive Services Among Adults With Disabilities

NCT00164476

COMPLETED Phase 2

Family Intervention for Suicidal Youth: Emergency Care

NCT00558805

COMPLETED Phase 1

Purdue University Parenting Program Attrition

NCT00153439

COMPLETED Phase 2

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

NCT00140309

COMPLETED Phase 3

Iron Supplementation Among Low-Income Postpartum Women

NCT00207610

COMPLETED NA

Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections

NCT00252096

COMPLETED Phase 2

Program Evaluation of People With Arthritis Can Exercise

NCT00153309

COMPLETED Phase 2

A Dissemination Trial of the Positive Parenting Program to Reduce Child Maltreatment in South Carolina

NCT00164606

COMPLETED NA

Comparing ASHC and CDSMP Outcomes In Arthritis

NCT00207441

COMPLETED NA

Pediatric Impact: Promoting Adherence to Medications Among HIV-infected Children

NCT00134602

COMPLETED NA

Using the Healthcare Visit to Improve Contraceptive Use

NCT00140296

COMPLETED NA

Shape Up Somerville: Eat Smart Play Hard

NCT00153322

COMPLETED NA

Utilization of the Community Popular Opinion Leader (C-POL) Model in Alabama

NCT00260754

COMPLETED NA

A Community-Based Intervention With Popular Opinion Leaders (C-POL) in Texas

NCT00260715

COMPLETED Phase 1

Ke Ala Lokahi Demonstration Project for Sexual and Domestic Violence Prevention

NCT00164268

← Previous Page 2 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 26
Phase 2 36
Phase 3 9
Phase 4 9

What is open in the Centers for Disease Control and Prevention pipeline

3 recruiting of 139 indexed (2% open); 131 completed (94%).

Phase mix: 18 late (III/IV) vs 62 early (I/II) (early-phase heavy).

Top condition: HIV Infections (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Centers for Disease Control and Prevention: open-pipeline peers nationwide

Peers matched on 139 registered trials and 2% open enrollment, not the therapeutic-area sidebar.

Centers for Disease Control and Prevention sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150 0%10%20%30% Total trials Recruiting share Centers for Disease Control and PreventionBarbara Ann Karmanos Cancer InstituteMclean HospitalShirley Ryan AbilityLabSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityBaxter Healthcare CorporationUSDA, Western Human Nutrition Research CenterSun Pharmaceutical IndustriesNSABP Foundation
Centers for Disease Control and Prevention sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Centers for Disease Control and Prevention sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 139 trials (± recruiting share)

Sponsors near 2% open enrollment (± trial volume)

What to do with this Centers for Disease Control and Prevention page

139 registered trials is a research-attention snapshot, not an endorsement of Centers for Disease Control and Prevention or any single study.

  • 3 of Centers for Disease Control and Prevention's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • HIV Infections is the condition Centers for Disease Control and Prevention studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Centers for Disease Control and Prevention pipeline card: 139 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.